Here - EWMA 2013

E-POSTER PRESENTATIONS
EP 464
E-Poster: Diabetic Foot
The Use of a Mesenchymal Stem Cell Living Skin Substitute in
Conjunction with Topical Oxygen for an Ischemic Post Operative
Transmetatarsal Amputation
Francis Derk 1 , Mike Griffiths 2
1 South Texas VA Medical Center (San Antonio, United States);
2 AOTI (Oceanside, United States).
Aim: A 66 yr/o Male with a hx of severe PVD, CVA, CHF, Hep C, s/p BKA, End Stage
Renal Dx, and DM Underwent a TMA of the Left foot secondary to Osteomyelitis and
infection. Immediately post operatively, the wound became escharotic and
dehisced.The patient was then placed on Topical Wound Oxygen Therapy for wound
staging and wound bed preparation. The patient underwent a Vascular Bypass Graft 5
months prior to the TMA procedure. Pre and Post NIs were N/C.
The patient was not a candidate for further vascular surgery and presented with a
natural hx of limb loss on the contralateral side prior secondary to PVD and infection.
Method: Application of Mesenchymal Stem Cell Living Skin Substitute within the
dehisced wound.Topical Wound Oxygen Therapy applied daily for 90 mins.
Results: Wound helaed completley in 9 weeks.
Conclusions/Discussion: Topical Wound Oxygen Therapy was very effcetive in wound
bed preperation and achieving rapid closure whne used in combination with
Mesenchymal Stem Cell Living Skin Substitute.
E-POSTER: DIABETIC FOOT
EP 465
Vakum therapy after minor amputations of diabetic foot
E-Poster: Diabetic Foot
Eugene Krivoshchekov 1 , Alexey Boklin 1 , Irina Dmitrieva 1
1 Samara State Medical University (Samara, Russia).
Objective: To show the effectiveness of the treatment of wounds of the foot injury by a
vacuum apparatus*.
Materials and Methods: Under the supervision of sostoyalo27 patients after amputation
at the small necrotic lesions stop. In group 1 (9 patients) were treated wounds with
antiseptic solutions. In group 2 (18 patients), the device* was applied. creating a
pressure of 125 mm Hg Duration of treatment – 7 days.
Results: In the first group of symptoms persisted at all. In the second group the
disappearance of the clinic was observed in all 12 persons. Inflammatory type cytogram
the end of one treatment group decreased by 11.8 + 1.2%, and 2 patients of 87.4 +1.1%.
Inflammatory and degenerative type cytogram in 1 group decreased by 10.8 + 1.2%, and
2 patients of 80.4 +1.1%. Regenerative type cytogram on day 10 was observed in 1
patient of group 1 and in all patients 2 groups. Significant difference in wound healing
persistent transition to the second phase in group 1 (p